| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 576.4 | 534.3 | 412.0 |
| Other income | 2.3 | 5.7 | 0.7 |
| Total income | 578.7 | 540.0 | 412.7 |
| Profit before exceptional items & tax | 116.9 | 110.4 | 71.7 |
| Profit before tax | 116.9 | 110.4 | 71.7 |
| Net profit | 90.4 | 84.8 | 53.9 |
| Operating margin | 20.2% | 20.4% | 17.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +67.70% |
|---|---|
| Net profit, quarter on quarter | +6.60% |
| Revenue, year on year | +39.90% |
| Operating profit, year on year | +61.40% |
| Operating profit, quarter on quarter | +9.50% |
BSE results filing, NSE: RUBICON. Figures extracted from the filing.
Rubicon Research Ltd: key numbers
- Share price
- ₹1,740.00
- Market cap
- ₹28,803 Cr
- Revenue (annual)
- ₹1,754 Cr
- Net profit (annual)
- ₹246.7 Cr
- P/E (TTM)
- 99.9×Sector 37.9×
- Promoter holding
- 51.25%-8.51% QoQ
- FII holding
- 9.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rubicon Research Ltd
All →Rubicon Research Other Announcement
Rubicon Research filed the India Ratings monitoring agency report for the IPO fresh issue proceeds for the quarter ended September 30, 2026. The agency found no deviation from the stated objects of the issue.
Rubicon Research Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹5,764Mn (+39.9%), EBITDA ₹1,464Mn (+54.1%, 25.4% margin), PAT ₹904Mn (+67.9%). Arinna consolidated; FY27 margin guidance raised to 24%+.
Rubicon Research Employee Stock Options
Rubicon Research Limited granted 68,982 stock options at an exercise price of Rs. 1,374.40 per share. The options vest over five years under the company's 2026 ESOP plan.
Rubicon Research Business Update
Rubicon Research disclosed a USFDA inspection of its Ambernath facility, which issued five procedural Form 483 observations. No monetary penalty or amount is involved.
Rubicon Research Board Meeting Date
Rubicon Research scheduled its Board for November 5, 2026, to consider unaudited financial results for the half year ended September 2026. Trading window closed since October 1.
Rubicon Research Other Announcement
Rubicon Research Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, pursuant to Regulation 31(1)(b) of the LODR Regulations.